SCHEMBL21779098

SCHEMBL21779098

COC1OC/C1=C\c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 2/20 0.41
CHRNB2 P17787 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA4 P43681 1/20 0.41
SERPINE1 P05121 1/20 0.35
AKR1C3 P42330 1/20 0.34
MAPT P10636 2/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CYP1A2 P05177 2/20 0.33
LMNA P02545 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TRPA1 O75762 1/20 0.32
EGFR P00533 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22375055 0.66 ALDH1A1 (0.49) MAPTCYP1A2LMNAALDH1A1EGFR
SCHEMBL118039 0.66 CHRNB2 (0.46) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL19010026 0.66 CHRNB2 (0.39) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL3418110 0.64 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL12474393 0.62 NFKB1 (0.41) CHRNB2CHRNB4CHRNA3CHRNA4SERPINE1
SCHEMBL3069464 0.61 ALDH1A1 (0.47) CHRNB2CHRNB4CHRNA3CHRNA4CYP1A2
Butadiene SCHEMBL4458837 0.60 HPGD (0.41) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
Bicarbonate SCHEMBL14660281 0.60 HPGD (0.41) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
Styrene SCHEMBL27658095 0.59 ALDH1A1 (0.54) MAPTCYP1A2CYP2C19SMN1; SMN2ALDH1A1
Styrene SCHEMBL693301 0.59 ALDH1A1 (0.54) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10577378-B2 EIF4A-inhibiting compounds and methods related thereto EFFECTOR THERAPEUTICS, INC. (US) 2020-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10577378-B2 EIF4A-inhibiting compounds and methods related thereto EIF4A1, EIF4A2, EIF4A3 CHRNA7 4813/4885CHRNB2 4808/4885CHRNB4 4825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.